COLA: Asthma guidelines
Session recorded on August 21, 2017.
Speaker: Michael B. Foggs, MD
Viewers can earn credit by completing the posttest questions.
Despite detailed evidence-based NAEPP Asthma Guidelines recommendations and guidance from international asthma guidelines, asthma management and control in US patients in many cases remains suboptimal and fall short of treatment targets. Some studies have demonstrated that 40 – 60% of asthmatics in the US have uncontrolled asthma. Therefore, this video provides a better understanding of asthma diagnosis, assessment, and treatment paradigms that may help satisfy the unmet needs to optimize asthma control and to decrease asthma morbidity and mortality.
Practicing Allergists / Immunologists
After viewing the video recording, learners should be able to…
- Describe the asthma paradigm of current impairment & future risk.
- Define asthma severity & asthma control & distinguish between the two.
- Discuss mechanisms by which airway remodeling can occur.
- Articulate potential damage to the airways caused by an asthma exacerbation.
Michael B. Foggs, MD
Chief of Allergy, Asthma & Immunology
Advocate Health Care
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
There is no commercial support for this activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance